Optiscan Platform Highly Accurate for Oral Cancer Diagnosis
Filed with ASX · · 2 pages · English
Optiscan Imaging Limited on 6ix
Earlier from Optiscan Imaging
- Optiscan Intends to pursue De Novo Pathway for InVivage
- OIL Appendix 4D and 31 December 2022 Half-year report
- Optiscan partners with Prolucid to develop AI Algorithms
- OIL December 2022 Quarterly Report and Appendix 4C
- Optiscan Managing Director 2022 AGM Presentation
Later from Optiscan Imaging
- OIL March 2023 Quarterly Report and Appendix 4C
- Trading Halt
- Optiscan Entitlement Issue Prospectus
- Optiscan Launches Entitlement Offer to Raise $16.7M
- Entitlement Offer Results and Shortfall Announcement
Follow Optiscan Imaging into a list and get an email when it puts out news.
Follow Optiscan Imaging